Aminoglutethimide

Aminoglutethimide (brand name Cytadren) is a medication used to treat certain types of breast cancer and Cushing's syndrome. It is a glucocorticoid inhibitor, which works by preventing the production of hormones in the adrenal gland, such as cortisol. This can help to reduce symptoms of Cushing's syndrome and slow the growth of certain breast cancer cells. Aminoglutethimide may also be used as part of a combination therapy to treat other types of cancer. It is available in tablet form and is usually taken twice a day. 

Aminoglutethimide, previously sold under brand names like Cytadren and Elipten, is a medication with a diverse history of medical uses. However, it is no longer widely used due to the availability of safer and more effective alternatives. Here's a breakdown of its key aspects:

Historical Uses:

  • Primarily used as an anticonvulsant to treat petit mal epilepsy (a type of absence seizure).
  • Used as a steroidogenesis inhibitor in treating:
    • Cushing's syndrome: a condition where the body produces too much cortisol (stress hormone).
    • Postmenopausal breast cancer: to block the production of estrogens that can fuel cancer growth (requires additional hormone replacement therapy).
    • Prostate cancer: to reduce testosterone levels and potentially slow cancer progression.

Current Status:

  • Not commonly used due to the emergence of safer and more effective medications for the above conditions.
  • Limited availability: due to less demand and potential for safer alternatives.
  • Not recommended for first-line treatment due to:
    • Side effects: including drowsiness, rash, hair loss, and potential for serious bone marrow suppression.
    • Drug interactions: can interact with various medications, increasing the risk of side effects.

Important Note:

  • This information is for general knowledge only and should not be interpreted as medical advice.
  • Always consult with a qualified healthcare professional for any questions or concerns regarding your specific situation and treatment options. They can provide the most up-to-date and personalized advice based on your individual needs and medical history.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L02 Endocrine therapy
L02B - Hormone antagonists and related agents
L02BG Aromatase inhibitors
External Links